Baldness/Hair Restoration

About Baldness/Hair Restoration Clinical Trials (Click to Open)
Join Clinical Trials for Baldness/Hair Restoration

Baldness/Hair Restoration

General Purpose:

Hair loss is commonly associated with baldness in men, however it is important to understand that it can affect both men and women, and can affect other areas of the body in addition to the scalp. Hair loss can occur as a result of hereditary factors, but can also occur as a side effect of certain medications or medical conditions. Anyone, regardless of age, sex, race, or ethnicity, can experience hair loss.

Hair loss from the scalp, or baldness, is addressed differently by different individuals. Some prefer to let their hair loss progress naturally and uninterrupted, and make no efforts to conceal it. Others prefer to use hairstyles, wigs, or accessories (such as a hat) to minimize the appearance of their baldness.

For some individuals, hair loss can be a source of emotional distress and/or an aesthetic concern, and as a result, they choose to pursue treatment to slow down or restore their hair loss.

If hair loss is negatively affecting your life, there are clinical trials available that may be able to help you. Some research is aimed at minimizing hair loss as a side effect of various medications and therapies, while others studies are working to develop new and more effective ways to slow its progression.

What Will Hair Loss Clinical Trials Be Like?

The types of procedures used in hair loss clinical trials will ultimately depend on the specific nature of the study and what aspect of hair loss is being studied. Provided below is a list of common procedures, tests, and assessments that may be incorporated into such clinical trials:

  • Detailed physical examination
  • A questionnaire or face-to-face interview to provide details related to your history of hair loss, which may include questions related to the following:
    • Date you first noticed your hair loss or thinning
    • Use of cosmetic and personal hygiene products
    • Family history of hair loss
    • Use of prescription or over-the-counter medications, including vitamins, minerals, and other dietary supplements.
    • Treatments you have attempted to use for your hair loss.
    • You may also be asked to use a specific shampoo and/or conditioner during the course of the study, or you may be asked to refrain from washing your hair or scalp.
    • Questionnaires to evaluate your stress level and/or emotional well-being.
    • Blood tests
    • Scalp or skin biopsy, depending on the location of your hair loss.
    • You may be asked to provide a hair sample for analysis.
    • Detailed examination and mapping of your scalp or other areas of hair loss.
    • Dietary logs
    • Photographs of your scalp or other areas of hair loss.
    • Use of lotions, creams, oral medications, or laser light therapy.

Typical Hair Loss Clinical Trial Protocol:

Specific examples of clinical trials for hair loss might include the following:

  • A clinical trial in which a newly-developed topical medication is applied to one-half of the scalp of individuals suffering from hair loss for a six month period. During this trial, individuals would be assessed at regular four week intervals to observe and document any new hair growth in previously-bald areas. Treating only one-half of the scalp allows the untreated half of the scalp to serve as a control.
  • A study in which women who have previously been treated for breast cancer with the chemotherapy drug docetaxel wear a special cap designed to provide a cooling effect on the scalp. The purpose of this study would be to determine if the use of such a cooling cap is safe and effective at preventing or minimizing hair loss associated with this particular chemotherapy regimen.
  • A study in which individuals who are experiencing significant hair loss due to a particular disease provide hair samples for analysis. The hair samples are then analyzed to determine the presence of a pre-defined set of vitamins and minerals. Based on each individual’s hair analysis, they are then prescribed a personalized diet and supplement regimen for a six month period. The purpose of this study would be to determine if personalized dietary modifications based on hair analysis are effective at slowing the progression of hair loss in patients with this particular disease.
  • A randomized clinical trial in which individuals with total-body hair loss are randomly assigned to receive either a newly developed drug designed to stimulate hair growth or a placebo.

A brief word about randomized trials and placebos: 

Many clinical trials involve the comparison of an investigational treatment to a “standard” treatment. Some studies determine which therapy a patient receives through a process known as randomization, in which patients are randomly assigned to receive either the investigational treatment or the standard treatment.

On occasion, a trial will investigate the use of a standard treatment plus a new drug compared to standard treatment plus a placebo. Placebos are inactive or “sham” treatments that are identical in appearance to the active treatment but have no therapeutic value.

Placebos are necessary to help determine if adverse effects that occur during the clinical trial are the result of the investigational treatment or due to some other factor. They also allow researchers to measure the effects of the active treatment and observe what would have happened without it.

In rare instances where no standard therapy exists, or when a new drug or therapy is being investigated, the investigational treatment might be compared to a placebo alone (such as the fourth clinical trial example described above). In these types of trials, those patients who are randomized to the placebo group do not receive an active treatment.

It is important to know that placebo-only trials are only conducted when scientifically necessary and when patients have been adequately informed that they may end up receiving the placebo rather than the active treatment. It is very important to note, however, that no one should ever participate in such a placebo trial when there is a widely available and highly effective standard treatment already in existence for their particular disease or condition.

Trial Eligibility and Medical Information Needed:

The type of clinical trial you may be eligible for often depends on many factors. Therefore, it is important to know as many details as possible with regard to your specific circumstances when searching for clinical trials.  Examples of information you may want to have on hand include the following:

  • Your history of hair loss
  • Your prior and current diagnoses of any other health conditions or diseases.
  • Your current medications (including vitamins, minerals, and other dietary supplements)

Suggested Search Terms:

 “hair loss female,” “hair loss male,” “hair loss child,” “hair loss treatment,” “hair loss stress,” “hair loss cancer,” “hair restoration,” “hair transplant,” “female pattern hair loss,” and “male pattern hair loss.” 

Current Search Term:

“Baldness/Hair Restoration”

Add Comments or Questions



Fraxel Laser for Alopecia


Condition:   Alopecia
Intervention:   Device: Fractional erbium-glass 1550 nm laser
Sponsor:   Northwestern University
Not yet recruiting


Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair


Condition:   Hair Thinning
Interventions:   Dietary Supplement: Nutrafol Supplement capsules;   Other: Placebo capsules
Sponsors:   Ablon Skin Institute Research Center;   Nutraceutical Wellness Inc.
Recruiting


Ocular Finding in Alopecia Areata


Condition:   Hair Loss
Intervention:  
Sponsor:   Assiut University
Not yet recruiting


Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata


Conditions:   Alopecia Areata;   Scarring Alopecia
Interventions:   Procedure: tSVF by lipoaspiration;   Procedure: PRP Concentration;   Procedure: Emulsification tSVF;   Procedure: cSVF isolation and concentration;   Procedure: cSVF in Normal Saline IV
Sponsors:   Regeneris Medical;   Global Alliance for Regenerative Medicine;   Healeon Medical Inc
Recruiting


Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females


Condition:   Hair Loss
Interventions:   Dietary Supplement: Nutrafol;   Dietary Supplement: placebo
Sponsor:   Sadick Research Group
Recruiting


Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia


Condition:   Alopecia, Androgenetic
Interventions:   Drug: P-3074;   Drug: Finasteride;   Drug: Vehicle
Sponsor:   Polichem S.A.
Active, not recruiting


Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy


Condition:   Alopecia
Intervention:   Device: Compression HeadBand
Sponsor:   Michael Milano, MD,PhD
Terminated


Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)


Condition:   Alopecia
Interventions:   Drug: CG 428 cutaneous solution;   Drug: Placebo cutaneous solution
Sponsor:   Legacy Healthcare SA
Recruiting


Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata


Condition:   Alopecia Areata
Interventions:   Drug: Apremilast;   Drug: Placebo
Sponsor:   Icahn School of Medicine at Mount Sinai
Active, not recruiting


A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata


Condition:   Alopecia Areata
Interventions:   Drug: Tralokinumab;   Drug: Placebo
Sponsor:   Emma.Guttman
Recruiting


A Study of Secukinumab for the Treatment of Alopecia Areata


Condition:   Alopecia Areata
Interventions:   Drug: Secukinumab;   Drug: Placebo
Sponsors:   Icahn School of Medicine at Mount Sinai;   Novartis
Terminated


Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment


Condition:   Androgenetic Alopecia
Interventions:   Device: Autologous Platelet Rich Plasma;   Device: Saline solution injection
Sponsor:   Regen Lab SA
Not yet recruiting


STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia


Condition:   Alopecia, Androgenetic
Interventions:   Device: Puregraft System;   Device: Celution System;   Procedure: Kerastem Therapy;   Procedure: Liposuction
Sponsor:   Kerastem Technologies, LLC
Active, not recruiting


Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL)


Conditions:   Female Pattern Baldness;   Alopecia, Androgenetic
Intervention:   Device: Hairstetics™ anchoring system
Sponsor:   Hairstetics
Not yet recruiting


Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis


Condition:   Alopecia Areata
Intervention:   Drug: Tofacitinib
Sponsors:   Julian M. Mackay-Wiggan;   Locks of Love
Active, not recruiting


Minoxidil Response Testing in Females With Female Pattern Hair Loss


Conditions:   Alopecia;   Female Pattern Hair Loss
Intervention:   Drug: 5% minoxidil topical foam
Sponsor:   Applied Biology, Inc.
Active, not recruiting


Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss


Condition:   Androgenetic Alopecia
Interventions:   Dietary Supplement: HCap Formula;   Dietary Supplement: Placebo
Sponsor:   Family Marketing
Completed


An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata


Condition:   Alopecia Areata
Intervention:   Drug: Abatacept
Sponsors:   Julian M. Mackay-Wiggan;   Bristol-Myers Squibb
Active, not recruiting


Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia


Condition:   Alopecia
Interventions:   Drug: Dutasteride;   Drug: Placebo
Sponsors:   Stiefel, a GSK Company;   GlaxoSmithKline
Completed


Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata


Condition:   Alopecia Areata
Intervention:   Drug: Ruxolitinib
Sponsors:   Columbia University;   Alopecia Areata Initiative - Gates Foundation;   Locks of Love
Completed


Intralesional Steroids in the Treatment of Alopecia Areata


Condition:   Alopecia Areata
Interventions:   Drug: Intralesional Triamcinolone 2.5 mg/ml;   Drug: Intralesional Triamcinolone 5 mg/ml;   Drug: Intralesional Triamcinolone 10 mg/ml;   Drug: Intralesional Saline
Sponsors:   Columbia University;   University of Minnesota - Clinical and Translational Science Institute
Recruiting


Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia


Condition:   Androgenetic Alopecia
Interventions:   Other: Human autologous hair follicle cells;   Other: Cell medium
Sponsors:   TrichoScience Innovations, Inc.;   Pharmalog Institut für klinische Forschung GmbH (PHARMALOG Institute for Clinical Research);   PRA Health Sciences;   Innovacell Biotechnologie AG;   DatInf (Germany);   The Hair and Skin Research and Treatment Center
Completed


A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia


Condition:   Alopecia
Intervention:   Drug: Dutasteride 0.5mg oral tablets
Sponsor:   GlaxoSmithKline
Completed


Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin


Condition:   Alopecia Areata
Intervention:   Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units
Sponsor:   University of British Columbia
Completed


Alefacept in Patients With Severe Scalp Alopecia Areata


Condition:   Alopecia Areata
Intervention:   Drug: Alefacept
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   National Alopecia Areata Foundation
Completed

Refine Your Search Advanced Search